Predictors of relapse in a fixed-dose, randomized, double-blind, 52-week relapse prevention trial of selegiline transdermal system

被引：0
|
作者：
Patkar, A. [1 ]
Jang, S. [1 ]
Jung, S. [1 ]
Pae, C. [1 ]
Jae, Y. [1 ]
Portland, K. [2 ]
机构：
[1] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA
[2] Dey Pharma LP, Med Affairs, Basking Ridge, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70380-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [21] Selegiline transdermal system for the treatment of major depressive disorder: An 8-week, double-blind, placebo-controlled, flexible-dose titration trial
    Feiger, Alan D.
    Rickels, Karl
    Rynn, Moira A.
    Zimbroff, Dan L.
    Robinson, Donald S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) : 1354 - 1361
  • [22] Sustained remission with cariprazine treatment: post hoc analysis of a randomized, double-blind, schizophrenia relapse prevention trial
    Correll, C. U.
    Potkin, S. G.
    Durgam, S.
    Cheng, C. T.
    Szatmari, B.
    Laszlovszky, I.
    Saliu, I.
    Earley, W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S935 - S936
  • [23] Efficacy of pantoprazole compared with omeprazole in prevention of relapse of reflux esophagitis: Double-blind, randomized multicenter trial.
    Lauritsen, K
    Jaup, B
    Carling, L
    Raptis, S
    Aadland, E
    Farkkila, M
    Elawaut, A
    Krejs, G
    Altorfer, J
    GASTROENTEROLOGY, 2000, 118 (04) : A18 - A18
  • [24] Comparison of Moisturizing Creams for the Prevention of Atopic Dermatitis Relapse: A Randomized Double-blind Controlled Multicentre Clinical Trial
    Akerstrom, Ulf
    Reitamo, Sakari
    Langeland, Tor
    Berg, Mats
    Rustad, Lisbeth
    Korhonen, Laura
    Loden, Marie
    Wiren, Karin
    Grande, Mats
    Skare, Petra
    Svensson, Ake
    ACTA DERMATO-VENEREOLOGICA, 2015, 95 (05) : 587 - 592
  • [25] Progesterone for smoking relapse prevention following delivery: A pilot, randomized, double-blind study
    Forray, Ariadna
    Gilstad-Hayden, Kathryn
    Suppies, Cristine
    Bogen, Debra
    Sofuoglu, Mehmet
    Yonkers, Kimberly A.
    PSYCHONEUROENDOCRINOLOGY, 2017, 86 : 96 - 103
  • [26] Efficacy and safety of clozapine versus chlorpromazine in first-episode psychosis: Results of a 52-week randomized double-blind trial
    Lieberman, JA
    Phillips, M
    Kong, L
    Gu, H
    Koch, G
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 236 - 236
  • [27] Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Double-Blind, Fixed-Dose Trial
    Goldman, Robert
    Hudson, James
    McElroy, Susan
    Grilo, Carlos
    Tsai, Joyce
    Deng, Ling
    Kent, Justine
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S108 - S108
  • [28] MINIMAL EFFECTIVE DOSE AND RELAPSE - DOUBLE-BLIND TRIAL - HALOPERIDOL DECANOATE VS PLACEBO
    EKLUND, K
    FORSMAN, A
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 : S7 - S15
  • [29] A randomized, placebo-controlled, double-blind, fixed-dose study of repaglinide.
    Cheatham, WW
    Strange, P
    DIABETOLOGIA, 1998, 41 : A235 - A235
  • [30] Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
    Durgam, Suresh
    Gommoll, Carl
    Migliore, Raffaele
    Chen, Changzheng
    Chang, Cheng-Tao
    Aguirre, Michelle
    Thase, Michael E.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (06) : 304 - 311
12345